DZ BANK AG analyst Peter Spengler maintained a Buy rating on Bayer (0P6S – Research Report) today. The company’s shares closed yesterday at ...
Bayer said on Wednesday it struck a global licence agreement for an experimental oral cancer drug for targeted therapies with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback
